PMP Pals Resources, Referrals and Support for Patients with Rare Intestinal Cancers, Appendiceal Cancer and Pseudomyxoma Peritonei http://www.pmppals.org/
[Multidisuilinary therapy for peritoneal dissemination using peritonectomy] PMID: 12484031 Gan To Kagaku Ryoho 2002 Nov;29(12):2178-83 Five-year survival rates of patients with gastric and colon cancer were 18% and 38%, respectively. Among various clinical factors, complete tumor resection was the most significant prognostic factor, and the prognosis of patients who underwent complete cytoreduction was significantly better than those who received incomplete cytoreduction. A multimodal therapy consisting of perioperative chemotherapy and peritonectomy with complete cytoreduction may be the most powerful method to treat patients with established peritoneal dissemination. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12484031&dopt=Abstract